No Data
No Data
Higasitetukou, Mitsui Sumitomo, etc. (additional) Rating.
Upgraded - Bullish Code Stock Name Securities Company Previous After --------------------------------------------------------- <9025> Konoike Transport Mizuho "Hold" "Buy" <6460> Sega Sammy HD Daiwa "2" "1" Downgraded - Bearish Code Stock Name Securities Company Previous After --------------------------------------------------------- <4
CellSource Slashes Final Dividend as Full-Year Profit Slumps 74%
CellSource: Notice regarding dividends from surplus
Stocks that moved the previous day part 1: Quolips, Ashiro, Zojirushi Mahobin, ETC.
Stock Name <Code> Closing Price on the 17th ⇒ Change from Previous Day DM Solute <6549> 1302 +442 Revised upward the Financial Estimates for Dividends for the fiscal year ending March 2025. Muromachi Chemical <4885> 828 +36 Revised upward the profit estimates for the first half. Tokyo Base <3415> 306 -21 Operating profit for the cumulative third quarter increased by 75.6%, but the progress rate against the full-year estimates remains at 40.2%. Qualips <4894> 5330 +705 Signed a joint research contract with Stanford University Department of Cardiothoracic Surgery. Asilo <
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○List of stocks converted to Sell in the market Code Stock Name Closing Price SAR Main Board <1377> Sakata Seed 3440 3520 <1663> K&O Energy 3125 3435 <1928> Sekisui House 3641 3712 <2168> Pasona 1989 2036 <2175> SMS 1615 1718 <2267> Yakult 3115 3315 <2337> Ichigo 3623 381
Stocks that moved the day before part 1 INTLOOP, Sakura Saku, ANYCOLOR, ETC.
Stock name <code> Closing price on the 13th ⇒ Change from the previous day. Jellybeans <3070> 113 +5 announced a partial change (expansion) in the Shareholder preferential treatment system. Daiko Tsusan <7673> 1340 +101 upwardly revised the second quarter performance estimates. INTLOOP <9556> 6200 +790 the first quarter operating profit is 2.8 times higher than the same period last year. Spider Plus <4192> 384 +34 introduced a Shareholder preferential treatment system. Hatena <3930> 1000 +7625 performance estimates for the fiscal year ending July.
No Data